@hepapredict.com
This company is a 3D spheroid system developed in an academic frame at Karolinska Institutet (Stockholm, Sweden).
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
HepaPredict AB is a contract research organization (CRO) that specializes in drug metabolism, toxicity, and drug development for liver disease. With a focus on improving preclinical selection of drug candidates for clinical development, they offer in-house evaluations of drug metabolism, pharmacokinetic properties, and safety. What sets HepaPredict apart is their unique 3D spheroid culture platform, which enables predictive in vivo metabolism and toxicity studies.
This platform, integrated with preclinical solutions and scientific consultancy, aims to shorten drug development times and reduce costs while developing novel medications for hepatic diseases. Founded in 2016 as a spin-off from Karolinska Institutet, HepaPredict AB brings together a team of experts led by Co-founder and CEO Assoc. Prof.
Volker M. Lauschke, PhD, MBA, with extensive experience in liver function and regeneration, hepatocyte differentiation plasticity, and the genetic basis of drug response. With their scientific experience and expertise, HepaPredict AB is committed to delivering highest-quality science to optimize drug development efficacy and safety
Company Type
Self-Owned
Company Size
2-10
Year Founded
2016
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories